mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.07 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.08 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.08 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.08 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.08 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.08 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.08 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.09 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.09 |